Petros Pharmaceuticals In...

NASDAQ: PTPI · Real-Time Price · USD
0.03
-0.00 (-10.18%)
At close: Jun 09, 2025, 3:15 PM

Petros Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-14.32M -8.16M -20.04M -8.99M
Depreciation & Amortization
2.94M 3.42M 5.6M 6.88M
Stock-Based Compensation
197.22K 417.23K 1.2M 1.31M
Other Working Capital
1.78M 752.72K -231.14K -3.67M
Other Non-Cash Items
4.05M -4.08M 3.75M 186.82K
Deferred Income Tax
n/a n/a n/a -9.48M
Change in Working Capital
4.53M 789.05K -3.3M -1.76M
Operating Cash Flow
-2.6M -7.63M -12.8M -11.86M
Capital Expenditures
-24.59K n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-24.59K n/a n/a n/a
Investing Cash Flow
-24.59K n/a n/a n/a
Debt Repayment
-765.28K -1.46M -1.62M -7.19M
Common Stock Repurchased
n/a -2M n/a n/a
Dividend Paid
-1.29B n/a n/a n/a
Other Financial Acitivies
1.29B 15M n/a 4.01M
Financial Cash Flow
-7M 11.54M -1.62M 18.57M
Net Cash Flow
-9.63M 3.91M -14.42M 6.71M
Free Cash Flow
-2.63M -7.63M -12.8M -11.86M